Coronary Guidewires Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Coronary Guidewires Pipeline Market Report Overview

A coronary guidewire is used to navigate catheters during angiography and Percutaneous Coronary Interventions (PCIs). The guidewire has an elongated body which provides flexibility. The three parts of a coronary guidewire include a central core, an outer covering, and a flexible distal tip.

The coronary guidewires pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The US

·       China

·       Europe

·       Australia

·       Canada

Key Regulatory Paths ·       510(k)

·       NMPA

·       PMA

·       CE

·       de novo

Leading Companies ·       Abbott Vascular Inc

·       AdenoPaint LLC

·       APT Medical Inc

·       Bioscan Technologies Inc.

·       Boston Scientific Corp

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Coronary Guidewires Pipeline Market Segmentation by Territories

A few of the key territories with the coronary guidewires pipeline market are the US, China, Europe, Australia, and Canada. As of April 2024, the US accounted for the highest number of pipeline products.

Coronary Guidewires Pipeline Market Analysis by Territories, 2024 (%)

Coronary Guidewires Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Coronary Guidewires Pipeline Market

Download a Free Report Sample

Coronary Guidewires Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the coronary guidewires pipeline products market are 510(k), NMPA, PMA, CE, and de novo, among others. As of April 2024, 510(k) was the most followed pathway for pipeline products in the coronary guidewires market.

Coronary Guidewires Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Coronary Guidewires Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Coronary Guidewires Pipeline Market

Download a Free Report Sample

Coronary Guidewires Pipeline Market – Competitive Landscape

A few of the key companies associated with the coronary guidewires pipeline market are Abbott Vascular Inc., AdenoPaint LLC, APT Medical Inc., Bioscan Technologies Inc., and Boston Scientific Corp, among others.

Abbott Vascular Inc: Abbott Vascular, headquartered in Santa Clara, California, the US, is a medical device company that develops, manufactures, and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. Abbott Vascular provides minimally invasive treatment for mitral regurgitation and other structural defects of the heart. It also offers education and training services for healthcare professionals.

Bio Scan Technologies Inc.: BioScan is headquartered in Yokneam, Israel. It is a medical equipment manufacturing company engaged in the development of diagnostic imaging products for cardiovascular markets. BioScan provides reconstructive images during percutaneous transluminal, coronary angioplasty, and stent placements. The company is developed using its patented optical ultrasonic technology. It is also engaged in research and development program.

Coronary Guidewires Pipeline Market Analysis by Companies, 2024

Coronary Guidewires Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Coronary Guidewires Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Coronary Guidewires Pipeline Market Territories Outlook (2024)

  • The US
  • China
  • Europe
  • Australia
  • Canada

Coronary Guidewires Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • NMPA
  • PMA
  • CE
  • de novo

Scope

This report provides:

  • Extensive coverage of the coronary guidewires under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of coronary guidewires and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of coronary guidewires under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Abbott Vascular Inc
AdenoPaint LLC
APT Medical Inc
Bioscan Technologies Inc.
Boston Scientific Corp
Cardiovascular Systems Inc
CorMetrics LLC
Echopoint Medical Ltd
ENDOMATERIALS
Georgia Institute of Technology
Guided Interventions, LLC
Infrared Sciences Corp
Koninklijke Philips NV
Microbot Medical Ltd
MicroPort Scientific Corp
NewMed Medical Co Ltd
Nirtek Pty Ltd
Opsens Inc
OVALUM Ltd
SoundBite Medical Solutions Inc
St. Jude Medical LLC
Terumo Corp
Terumo Interventional Systems
The Cleveland Clinic Foundation
Three Rivers Cardiovascular Systems Inc
Transmural systems LLC
University of Illinois at Chicago
Vasostar Ltd.
Xenter Inc

Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 9

2 Introduction 10

2.1 Coronary Guidewires Overview 10

3 Products under Development 11

3.1 Coronary Guidewires – Pipeline Products by Stage of Development 11

3.2 Coronary Guidewires – Pipeline Products by Territory 12

3.3 Coronary Guidewires – Pipeline Products by Regulatory Path 13

3.4 Coronary Guidewires – Pipeline Products by Estimated Approval Date 14

3.5 Coronary Guidewires – Ongoing Clinical Trials 15

4 Coronary Guidewires – Pipeline Products under Development by Companies 16

4.1 Coronary Guidewires Companies – Pipeline Products by Stage of Development 16

4.2 Coronary Guidewires – Pipeline Products by Stage of Development 18

5 Coronary Guidewires Companies and Product Overview 19

5.1 Abbott Vascular Inc Company Overview 19

5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.2 AdenoPaint LLC Company Overview 20

5.2.1 AdenoPaint LLC Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 APT Medical Inc Company Overview 21

5.3.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.4 Bioscan Technologies Inc. Company Overview 23

5.4.1 Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 23

5.5 Boston Scientific Corp Company Overview 24

5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 24

5.6 Cardiovascular Systems Inc Company Overview 26

5.6.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 CorMetrics LLC Company Overview 27

5.7.1 CorMetrics LLC Pipeline Products & Ongoing Clinical Trials Overview 27

5.8 Echopoint Medical Ltd Company Overview 28

5.8.1 Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

5.9 ENDOMATERIALS Company Overview 29

5.9.1 ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 Georgia Institute of Technology Company Overview 30

5.10.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 30

5.11 Guided Interventions, LLC Company Overview 31

5.11.1 Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview 31

5.12 Infrared Sciences Corp Company Overview 32

5.12.1 Infrared Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 32

5.13 Koninklijke Philips NV Company Overview 33

5.13.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 33

5.14 Microbot Medical Ltd Company Overview 34

5.14.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

5.15 MicroPort Scientific Corp Company Overview 35

5.15.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 35

5.16 NewMed Medical Co Ltd Company Overview 37

5.16.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

5.17 Nirtek Pty Ltd Company Overview 38

5.17.1 Nirtek Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

5.18 Opsens Inc Company Overview 39

5.18.1 Opsens Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.19 OVALUM Ltd Company Overview 42

5.19.1 OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

5.20 SoundBite Medical Solutions Inc Company Overview 43

5.20.1 SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.21 St. Jude Medical LLC Company Overview 44

5.21.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 44

5.22 Terumo Corp Company Overview 45

5.22.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 45

5.23 Terumo Interventional Systems Company Overview 46

5.23.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 46

5.24 The Cleveland Clinic Foundation Company Overview 47

5.24.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 47

5.25 Three Rivers Cardiovascular Systems Inc Company Overview 48

5.25.1 Three Rivers Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.26 Transmural systems LLC Company Overview 49

5.26.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview 49

5.27 University of Illinois at Chicago Company Overview 52

5.27.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 52

5.28 Vasostar Ltd. Company Overview 53

5.28.1 Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview 53

5.29 Xenter Inc Company Overview 56

5.29.1 Xenter Inc Pipeline Products & Ongoing Clinical Trials Overview 56

6 Coronary Guidewires- Recent Developments 57

6.1 Apr 04, 2024: AngioDynamics Reports Results for the Quarter Ended In February 57

6.2 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 57

6.3 Feb 28, 2024: Merit Medical Introduces ‘Continued Growth Initiatives’ Program and Financial Targets for Three-Year Period Ending December 31, 2026 57

6.4 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company 57

6.5 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering 58

6.6 Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent 58

6.7 Feb 07, 2024: Terumo Announces Change of Executive Officers (PDF

232.27 KB) 58

6.8 Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023 58

6.9 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results 60

6.10 Jan 05, 2024: AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance 60

6.11 Dec 18, 2023: Merit Medical Announces Process for Chief Executive Officer Succession Planning 62

6.12 Nov 10, 2023: Microport Appointment of Director 62

6.13 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023 63

6.14 Oct 23, 2023: OPSENS Announces the Positive Clinical Results from the SAFE-TAVI Study with Savvywire in Europe 65

6.15 Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range 66

6.16 Oct 17, 2023: Opsens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) In San Francisco October 23 – 26, 2023 68

6.17 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 68

6.18 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer 69

6.19 Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report 69

6.20 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources 71

6.21 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 72

6.22 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 72

6.23 Aug 07, 2023: Cleveland Clinic Appoints Albert Marinez as its First Chief Analytics Officer 72

6.24 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility 72

6.25 Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 73

6.26 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1 73

6.27 May 15, 2023: Asahi Intecc Co. announces consolidated financial results for the nine months ended March 31, 2023 73

6.28 May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023 73

6.29 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 73

6.30 May 10, 2023: Opsens announces inclusion of Savvywire in complete TAVR study 74

7 Appendix 75

7.1 Methodology 75

7.2 About GlobalData 78

7.3 Contact Us 78

7.4 Disclaimer 78

Table

Coronary Guidewires – Pipeline Products by Stage of Development 11

Coronary Guidewires – Pipeline Products by Territory 12

Coronary Guidewires – Pipeline Products by Regulatory Path 13

Coronary Guidewires – Pipeline Products by Estimated Approval Date 14

Coronary Guidewires – Ongoing Clinical Trials 15

Coronary Guidewires Companies – Pipeline Products by Stage of Development 16

Coronary Guidewires – Pipeline Products by Stage of Development 18

Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Hi-Torque Vector – Product Status 19

Hi-Torque Vector – Product Description 19

AdenoPaint LLC Pipeline Products & Ongoing Clinical Trials Overview 20

Adenowire – Product Status 20

Adenowire – Product Description 20

APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21

SCG Guidewire – Product Status 21

SCG Guidewire – Product Description 21

WCG Guidewire – Product Status 22

WCG Guidewire – Product Description 22

Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 23

Lightwire – Product Status 23

Lightwire – Product Description 23

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 24

Crossing Wire – Product Status 24

Crossing Wire – Product Description 24

Rotawire Drive – Product Status 25

Rotawire Drive – Product Description 25

Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 26

ZILIENT Guidewire – Coronary Intervention – Product Status 26

ZILIENT Guidewire – Coronary Intervention – Product Description 26

CorMetrics LLC Pipeline Products & Ongoing Clinical Trials Overview 27

Fractional Flow Reserve Guide Wire System – Product Status 27

Fractional Flow Reserve Guide Wire System – Product Description 27

Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

iKOs Guidewire – Coronary Intervention – Product Status 28

iKOs Guidewire – Coronary Intervention – Product Description 28

ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview 29

Multimodal Sensing Guidewire – Product Status 29

Multimodal Sensing Guidewire – Product Description 29

Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 30

Intravascular Ultrasound Imaging Guidewire – Product Status 30

Intravascular Ultrasound Imaging Guidewire – Product Description 30

Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview 31

Pressure Sensing Coronary Artery Guide Wire – Product Status 31

Pressure Sensing Coronary Artery Guide Wire – Product Description 31

Infrared Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 32

Steerable Guidewire – Product Status 32

Steerable Guidewire – Product Description 32

Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 33

ComboWire Plus Pressure And Flow Wire – Product Status 33

ComboWire Plus Pressure And Flow Wire – Product Description 33

Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

CardioSert – Double Concentric Guidewire – Product Status 34

CardioSert – Double Concentric Guidewire – Product Description 34

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 35

Micro-Guide Wire – Product Status 35

Micro-Guide Wire – Product Description 35

Pressure Guidewire – Product Status 36

Pressure Guidewire – Product Description 36

NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

Guide Wire – Product Status 37

Guide Wire – Product Description 37

Nirtek Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

NIRAF Guidewire – Product Status 38

NIRAF Guidewire – Product Description 38

Opsens Inc Pipeline Products & Ongoing Clinical Trials Overview 39

SavvyWire – Product Status 39

SavvyWire – Product Description 39

Opsens Inc – Ongoing Clinical Trials Overview 40

SavvyWire – A Randomized, Comparative Effectiveness Study of Staged Complete Revascularization With Percutaneous Coronary Intervention to Treat Coronary Artery Disease vs Medical Management Alone in Patients with Symptomatic Aortic Valve Stenosis Undergoing Elective Transfemoral Transcatheter Aortic Valve Replacement: The COMPLETE TAVR Study 41

SavvyWire – Evaluation of the Aortic Regurgitation Index (ARi) Measured With the Opsens SavvyWire to Determine the Correlation Between Regurgitation Evaluation Using Echography and Aortography 41

OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

OctoBooster Extension Guidewire – Product Status 42

OctoBooster Extension Guidewire – Product Description 42

SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 43

SoundBite Active Wire – Coronary – Product Status 43

SoundBite Active Wire – Coronary – Product Description 43

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 44

Sensor Enabled – Quadra Excel Guidewire – Product Status 44

Sensor Enabled – Quadra Excel Guidewire – Product Description 44

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 45

Izanai – Product Status 45

Izanai – Product Description 45

Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 46

Wrist Artery Guidewire – Product Status 46

Wrist Artery Guidewire – Product Description 46

The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 47

CTO Guidewire – Product Status 47

CTO Guidewire – Product Description 47

Three Rivers Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 48

SmartGuidewire – Product Status 48

SmartGuidewire – Product Description 48

Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview 49

TELLTALE Electrosurgical Guidewire System – Product Status 49

TELLTALE Electrosurgical Guidewire System – Product Description 49

Transmural systems LLC – Ongoing Clinical Trials Overview 50

TELLTALE Electrosurgical Guidewire System – NHLBI Transmural Electrosurgery LeafLet Traversal and Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial 51

University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 52

CTO Wire – Product Status 52

CTO Wire – Product Description 52

Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview 53

VasoStar Vibrational Guidewire System – Product Status 53

VasoStar Vibrational Guidewire System – Product Description 53

Vasostar Ltd. – Ongoing Clinical Trials Overview 54

VasoStar Vibrational Guidewire System – Evaluation of a Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions in Patients With Chronic Angina Refractory to Maximally Tolerated Guideline Directed Medical Therapy 55

Xenter Inc Pipeline Products & Ongoing Clinical Trials Overview 56

TAVR SmartWire – Product Status 56

TAVR SmartWire – Product Description 56

Glossary 77

Figures

Coronary Guidewires – Pipeline Products by Stage of Development 10

Coronary Guidewires – Pipeline Products by Territory 11

Coronary Guidewires – Pipeline Products by Regulatory Path 12

Coronary Guidewires – Pipeline Products by Estimated Approval Date 13

Coronary Guidewires – Ongoing Clinical Trials 14

Frequently asked questions

Coronary Guidewires Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Coronary Guidewires Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Coronary Guidewires Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Coronary Guidewires Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.